Evaluation and Analysis of the Rationality of Clinical Use of Carbapenems in Surgical Departments of a Tertiary Hospital in Southwest China

References

• Browne AJ, Chipeta MG, Haines-Woodhouse G, et al. Global antibiotic consumption and usage in humans, 2000–18: a spatial modelling study. Lancet Planetary Health. 2021;5(12):e893–e904. doi:10.1016/S2542-5196(21)00280-1
   PubMedGoogle Scholar
• Murray CJ, Ikuta KS, Sharara F, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–655. doi:10.1016/S0140-6736(21)02724-0
   PubMed Web of Science ®Google Scholar
• Zequinão T, Telles JP, Gasparetto J, Tuon FF. Carbapenem stewardship with ertapenem and antimicrobial resistance-A scoping review. Rev Soc Bras Med Trop. 2020;53. doi:10.1590/0037-8682-0413-2020
   PubMed Web of Science ®Google Scholar
• Sadyrbaeva-Dolgova S, Aznarte-Padial P, Jimenez-Morales A, Expósito-Ruiz M, Calleja-Hernández MÁ, Hidalgo-Tenorio C. Pharmacist recommendations for carbapenem de-escalation in urinary tract infection within an antimicrobial stewardship program. J Infect Public Health. 2020;13(4):558–563. doi:10.1016/j.jiph.2019.09.014
   PubMed Web of Science ®Google Scholar
• López-Viñau T, Peñalva G, García-Martínez L, et al. Impact of an antimicrobial stewardship program on the incidence of carbapenem resistant Gram-negative bacilli: an interrupted time-series analysis. Antibiotics. 2021;10(5):586. doi:10.3390/antibiotics10050586
   Google Scholar
• Peri AM, Doi Y, Potoski BA, Harris PN, Paterson DL, Righi E. Antimicrobial treatment challenges in the era of carbapenem resistance. Diagn Microbiol Infect Dis. 2019;94(4):413–425. doi:10.1016/j.diagmicrobio.2019.01.020
   PubMed Web of Science ®Google Scholar
• Nordmann P, Poirel L. Epidemiology and diagnostics of carbapenem resistance in gram-negative bacteria. Clin Infect Dis. 2019;69(Supplement_7):S521–S528. doi:10.1093/cid/ciz824
   PubMed Web of Science ®Google Scholar
• Hu F, Guo Y, Zhu D, et al. CHINET surveillance of bacterial resistance across China: report of the results in 2016. Chin J Infect Chemother. 2017;24:481–491.
   Google Scholar
• Hu F, Zhu D, Wang F, Wang M. Current status and trends of antibacterial resistance in China. Clin Infect Dis. 2018;67(suppl_2):S128–S134. doi:10.1093/cid/ciy657
   PubMed Web of Science ®Google Scholar
• Qu X, Yin C, Sun X, et al. Consumption of antibiotics in Chinese public general tertiary hospitals (2011–2014): trends, pattern changes and regional differences. PLoS One. 2018;13(5):e0196668. doi:10.1371/journal.pone.0196668
   PubMed Web of Science ®Google Scholar
• Hao Y, Chen S, Chang H, et al. Temporal association between Carbapenems usage and antimicrobial resistance in gram-negative bacteria at a tertiary hospital in Nanjing, China. Diagn Microbiol Infect Dis. 2020;98(2):115083. doi:10.1016/j.diagmicrobio.2020.115083
   PubMed Web of Science ®Google Scholar
• National Health Commission of the People’s Republic of China. 2020 national bacterial resistance surveillance report. 2020.
   Google Scholar
• National Health Commission of the People’s Republic of China. Expert consensus on the clinical application of carbapenems in China. 2018.
   Google Scholar
• Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect. 2010;11(1):79–109. doi:10.1089/sur.2009.9930
   PubMed Web of Science ®Google Scholar
• Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181–1247. doi:10.1007/s00134-021-06506-y
   PubMed Web of Science ®Google Scholar
• Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. Infectious Diseases Society of America 2022 guidance on the treatment of extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa). Clin Infect Dis. 2022;75(2):187–212. doi:10.1093/cid/ciac268
   PubMed Web of Science ®Google Scholar
• Badia JM, Batlle M, Juvany M, et al. Surgeon-led 7-VINCut antibiotic stewardship intervention decreases duration of treatment and carbapenem use in a general surgery service. Antibiotics. 2020;10(1):11. doi:10.3390/antibiotics10010011
   Google Scholar
• Poline J, Postaire M, Parize P, et al. Stewardship program on carbapenem prescriptions in a tertiary hospital for adults and children in France: a cohort study. Eur J Clin Microbiol Infect Dis. 2021;40(5):1039–1048. doi:10.1007/s10096-020-04103-3
   PubMed Web of Science ®Google Scholar
• Suzuki H, Perencevich E, Goto M, et al. A comprehensive assessment of carbapenem use across 90 Veterans Health Administration hospitals with defined stewardship strategies for carbapenems. J Antimicrob Chemother. 2021;76(5):1358–1365. doi:10.1093/jac/dkab008
   PubMed Web of Science ®Google Scholar
• Zhang D, Cui K, Lu W, et al. Evaluation of carbapenem use in a tertiary hospital: antimicrobial stewardship urgently needed. Antimicrob Resist Infect Control. 2019;8(1):1–7. doi:10.1186/s13756-018-0449-3
   PubMedGoogle Scholar
• Patrier J, Timsit J-F. Carbapenem use in critically ill patients. Curr Opin Infect Dis. 2020;33(1):86–91. doi:10.1097/QCO.0000000000000622
   PubMed Web of Science ®Google Scholar
• Wagner JL, Rhodes NJ, Scheetz MH, et al. Opportunities for antimicrobial stewardship among carbapenem-treated patients in 18 North American hospitals. Int J Antimicrob Agents. 2020;55(6):105970. doi:10.1016/j.ijantimicag.2020.105970
   PubMed Web of Science ®Google Scholar
• Charani E, Tarrant C, Moorthy K, Sevdalis N, Brennan L, Holmes A. Understanding antibiotic decision making in surgery—a qualitative analysis. Clin Microbiol Infect. 2017;23(10):752–760. doi:10.1016/j.cmi.2017.03.013
   PubMed Web of Science ®Google Scholar
• Charani E, Ahmad R, Rawson T, Castro-Sanchèz E, Tarrant C, Holmes A. The differences in antibiotic decision-making between acute surgical and acute medical teams: an ethnographic study of culture and team dynamics. Clin Infect Dis. 2019;69(1):12–20. doi:10.1093/cid/ciy844
   PubMed Web of Science ®Google Scholar
• Olusoga A, Howard P, Walker C, Atack K, Waterhouse A. Carbapenem stewardship in a large teaching English hospital-are we improving? Access Microbiol. 2020;2(2):164. doi:10.1099/acmi.fis2019.po0162
   Google Scholar
• Perron J, Baldolli A, Isnard C, de La Blanchardière A, Saint-Lorant G. Assessing the relevance of carbapenem prescriptions by an antibiotic stewardship team. Médecine et Maladies Infectieuses. 2020;50(4):346–351. doi:10.1016/j.medmal.2019.06.004
   PubMed Web of Science ®Google Scholar
• Bahrampour Juybari K, Vosooghi V, Zahmatkesh M, Mirmohammadkhani M, Paknazar F. Compliance of imipenem and meropenem administration with the national antimicrobial stewardship program in a referral teaching hospital in Iran. Hosp Pract. 2022;50(1):49–54. doi:10.1080/21548331.2021.2022358
   PubMedGoogle Scholar
• Lee C-R, Lee JH, Kang L-W, Jeong BC, Lee SH. Educational effectiveness, target, and content for prudent antibiotic use. Biomed Res Int. 2015;2015. doi:10.1155/2015/214021
   Web of Science ®Google Scholar
• Gluhovschi C, Gadalean F, Velciov S, et al. Acute acalculous cholecystitis associated with abscesses—an unknown dual pathology. Biomedicines. 2023;11(2):632. doi:10.3390/biomedicines11020632
   PubMed Web of Science ®Google Scholar
• Suh S-W, Choi YS, Choi S-H, et al. Antibiotic selection based on microbiology and resistance profiles of bile from gallbladder of patients with acute cholecystitis. Sci Rep. 2021;11(1):2969. doi:10.1038/s41598-021-82603-8
   PubMed Web of Science ®Google Scholar
• Sartelli M, Hardcastle C, Catena F, et al. Antibiotic use in low and middle-income countries and the challenges of antimicrobial resistance in surgery. Antibiotics. 2020;9(8):497. doi:10.3390/antibiotics9080497
   Web of Science ®Google Scholar
• Lancet T; Lancet. Protecting Chinese doctors. Lancet. 2020;395:90. doi:10.1016/S0140-6736(20)30003-9
   Web of Science ®Google Scholar
• Xin C, Xia Z, Li G. The impact of pharmaceutical interventions on the use of carbapenems in a Chinese hospital: a pre–post study. Infect Drug Resist. 2019;12:3567. doi:10.2147/IDR.S229009
   PubMed Web of Science ®Google Scholar
• Akazawa T, Kusama Y, Fukuda H, et al. Eight-Year Experience of Antimicrobial Stewardship Program and the Trend of Carbapenem Use at a Tertiary Acute-Care Hospital in Japan—the Impact of Postprescription Review and Feedback. Oxford University Press US; 2019:ofz389.
   Google Scholar
• Fortini A, Faraone A, Di Pietro M, et al. Antimicrobial stewardship in an Internal Medicine ward: effects on antibiotic consumption and on the use of carbapenems. Intern Emerg Med. 2018;13(8):1219–1226. doi:10.1007/s11739-018-1916-9
   PubMed Web of Science ®Google Scholar
• García-Rodríguez JF, Bardan-Garcia B, Juiz-Gonzalez PM, Vilarino-Maneiro L, Alvarez-Diaz H, Marino-Callejo A. Long-term carbapenems antimicrobial stewardship program. Antibiotics. 2020;10(1):15. doi:10.3390/antibiotics10010015
   Google Scholar
• Yusef D, Hayajneh WA, Bani Issa A, et al. Impact of an antimicrobial stewardship programme on reducing broad-spectrum antibiotic use and its effect on carbapenem-resistant Acinetobacter baumannii (CRAb) in hospitals in Jordan. J Antimicrob Chemother. 2021;76(2):516–523. doi:10.1093/jac/dkaa464
   PubMed Web of Science ®Google Scholar
• Faraone A, Poggi A, Cappugi C, et al. Inappropriate use of carbapenems in an internal medicine ward: impact of a carbapenem-focused antimicrobial stewardship program. Eur J Intern Med. 2020;78:50–57. doi:10.1016/j.ejim.2020.03.017
   PubMed Web of Science ®Google Scholar
• Okeah BO, Morrison V, Huws JC. Antimicrobial stewardship and infection prevention interventions targeting healthcare-associated Clostridioides difficile and carbapenem-resistant Klebsiella pneumoniae infections: a scoping review. BMJ open. 2021;11(8):e051983. doi:10.1136/bmjopen-2021-051983
   PubMed Web of Science ®Google Scholar
• Wilson APR. Sparing carbapenem usage. J Antimicrob Chemother. 2017;72(9):2410–2417. doi:10.1093/jac/dkx181
   PubMed Web of Science ®Google Scholar
• Li Y-Y, Wang J, Wang R, Cai Y. Double-carbapenem therapy in the treatment of multidrug resistant Gram-negative bacterial infections: a systematic review and meta-analysis. BMC Infect Dis. 2020;20(1):1–13.
   Web of Science ®Google Scholar
• Schneider F, Gessner A, El-Najjar N. Efficacy of vancomycin and meropenem in central nervous system infections in children and adults: current update. Antibiotics. 2022;11(2):173. doi:10.3390/antibiotics11020173
   Google Scholar
• Bookstaver PB, Bland CM, Griffin B, Stover KR, Eiland LS, McLaughlin M. A review of antibiotic use in pregnancy. Pharmacotherapy. 2015;35(11):1052–1062. doi:10.1002/phar.1649
   PubMed Web of Science ®Google Scholar
• Wu -C-C, Pai T-Y, Hsiao F-Y, Shen L-J, Wu F-L-L. The effect of different carbapenem antibiotics (ertapenem, imipenem/ cilastatin, and meropenem) on serum valproic acid concentrations. Ther Drug Monit. 2016;38(5):587–592. doi:10.1097/FTD.0000000000000316
   PubMed Web of Science ®Google Scholar
• Al-Quteimat O, Laila A. Valproate interaction with carbapenems: review and recommendations. Hosp Pharm. 2020;55(3):181–187. doi:10.1177/0018578719831974
   PubMed Web of Science ®Google Scholar
• Heo Y-A. Imipenem/cilastatin/relebactam: a review in Gram-negative bacterial infections. Drugs. 2021;81:377–388. doi:10.1007/s40265-021-01471-8
   PubMed Web of Science ®Google Scholar